Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy

Zhen Li,Isra Rana,Gyungdeuk Park,Jinwoo Lee,Chae Eun Park,Jutaek Nam
DOI: https://doi.org/10.1007/s40005-023-00633-y
2023-09-22
Journal of Pharmaceutical Investigation
Abstract:Pattern recognition receptors (PRRs) are crucial immune modulators that orchestrate innate and adaptive immune systems for the regulation of inflammatory responses. Several PRR families and their ligands associated with immune modulation have been identified, which promoted the development of natural and synthetic PRR agonistic ligands as adjuvants in immunotherapy applications. However, conventional adjuvants are mainly based on small molecules, peptides, lipids, and oligonucleotides, which suffer from unfavorable drug-like properties for in vivo applications, including vulnerability to biodegradation, undesirable pharmacokinetic profiles, and poor cellular uptake. Nanoparticle formulation is a promising approach for addressing the issues with conventional adjuvants.
English Else
What problem does this paper attempt to address?